A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.

NCT00141934 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
232
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sosei